Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04150029 |
Title | A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy (STIMULUS-AML1) |
Acronym | STIMULUS-AML1 |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA | ITA | FRA | ESP | DEU | CAN | AUS |